Reporte zur Charge 2SNM39

Symptomtext

adult patient given pediatric dose; adult patient given pediatric dose; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 33-year-old female patient who received HBV (Engerix B) (batch number 2SNM39, expiry date 16th March 2024) for prophylaxis. On 4th March 2022, the patient received Engerix B. On 4th March 2022, unknown after receiving Engerix B, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown. Additional details were provided as follows: The reporter was a pharmacy intern. The reporter reported that an adult patient was given a pediatric dose of Engerix-B, which led to underdose and adult use of a child product. The reporter did not consent to follow-up.